Interpace Biosciences (IDXG) Competitors

Laboratory Co. of America (NYSE:LH) and Interpace Biosciences (NASDAQ:IDXG) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, community ranking, institutional ownership, earnings, analyst recommendations, valuation and dividends.

Which has stronger earnings and valuation, LH or IDXG?

Laboratory Co. of America has higher revenue and earnings than Interpace Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Laboratory Co. of America	$13.01B	1.61	$746M	$8.82	28.33
Interpace Biosciences	$40.21M	0.14	$800K	N/A	N/A

Do institutionals and insiders believe in LH or IDXG?

95.9% of Laboratory Co. of America shares are held by institutional investors. Comparatively, 5.7% of Interpace Biosciences shares are held by institutional investors. 0.9% of Laboratory Co. of America shares are held by insiders. Comparatively, 5.5% of Interpace Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Is LH or IDXG more profitable?

Interpace Biosciences has a net margin of 10.39% compared to Laboratory Co. of America's net margin of 5.73%. Laboratory Co. of America's return on equity of 15.29% beat Interpace Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Laboratory Co. of America	5.73%	15.29%	7.01%
Interpace Biosciences	10.39%	-8.09%	37.14%

Do analysts prefer LH or IDXG?

Laboratory Co. of America currently has a consensus price target of $265.31, indicating a potential upside of 6.18%. Given Laboratory Co. of America's stronger consensus rating and higher probable upside, equities analysts plainly believe Laboratory Co. of America is more favorable than Interpace Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Laboratory Co. of America	0 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.88
Interpace Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Does the MarketBeat Community prefer LH or IDXG?

Laboratory Co. of America received 303 more outperform votes than Interpace Biosciences when rated by MarketBeat users. However, 72.83% of users gave Interpace Biosciences an outperform vote while only 63.99% of users gave Laboratory Co. of America an outperform vote.

Company	Underperform	Outperform
Laboratory Co. of America	Outperform Votes 622 63.99%	Underperform Votes 350 36.01%
Interpace Biosciences	Outperform Votes 319 72.83%	Underperform Votes 119 27.17%

Which has more risk and volatility, LH or IDXG?

Laboratory Co. of America has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Comparatively, Interpace Biosciences has a beta of 0.76, indicating that its share price is 24% less volatile than the S&P 500.

Does the media prefer LH or IDXG?

In the previous week, Laboratory Co. of America had 14 more articles in the media than Interpace Biosciences. MarketBeat recorded 14 mentions for Laboratory Co. of America and 0 mentions for Interpace Biosciences. Laboratory Co. of America's average media sentiment score of 1.38 beat Interpace Biosciences' score of 0.00 indicating that Laboratory Co. of America is being referred to more favorably in the media.

Company	Overall Sentiment
Laboratory Co. of America	Positive
Interpace Biosciences	Neutral

Summary

Laboratory Co. of America beats Interpace Biosciences on 13 of the 17 factors compared between the two stocks.